Actos Patients: The One Year Mark & Cumulative Exposure

May 20, 2012

Type 2 diabetes patients should be aware that the U.S. Food and Drug Administration (FDA) has warned that the use of Actos (pioglitazone), a prominent diabetes medication, for longer than one year has been linked to a notably increased risk of bladder cancer. In fact, although the one year mark is important, the FDA has also noted that the correlation between treatment and cancer risk is perhaps more closely tied to cumulative pioglitazone exposure. As the one year mark approaches, cumulative exposure for most patients tends to near a kind of tipping point in which bladder cancer risk dramatically rises.

 

Are you ready to find out more about the risks of bladder cancer and Actos (pioglitazone), one of its possible causes? This isn’t simply a medical issue for some patients, but a legal issue, too. Find out what your first steps need to be by contacting the attorneys and professionals at the law firm of Fears Nachawati today. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

More Blog Posts

CONTACT US

Use the form below to send us a note, call us at 214.890.0711 or chat with us live. We are eager to help with all your legal needs. Please keep in mind that any unsolicited information sent through our website cannot be treated as confidential. Contacting us through this site does not create a representation relationship with Fears Nachawati.

Inquiry Type

  • General
  • Personal Injury
  • Immigration
  • Bankruptcy
  • Drug Litigation
  • Family Law

Locations

With offices in Texas, Florida and Colorado and attorneys licensed in Texas, Florida, Colorado, Arkansas and Oklahoma, Fears Nachawati is dedicated to attaining the best possible solutions for our clients’ business and personal needs. We strive to be professionals who are creative, empathetic and reliable.

All Areas Served

We Can Help

Contact Fears Nachawati today

Free Consulation

Live Chat (Online Now)